David I Broadhurst

Prof. David I Broadhurst

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2011 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
TCThe Human Serum Metabolome (HUSERMET) Consortium
The Human Serum Metabolome (HUSERMET) Consortium
WDWarwick Dunn
Warwick Dunn
DBDavid I Broadhurst
David I Broadhurst
PBPaul Begley
Paul Begley
EZEva Zelena
Eva Zelena
RGRoyston Goodacre
Royston Goodacre

2 May 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
Jianguo XiaJianguo Xia
Jianguo Xia
RMR. Mandal
R. Mandal
ISI. V. Sinelnikov
I. V. Sinelnikov
DBDavid I Broadhurst
David I Broadhurst
David Scott WishartDavid Scott Wishart
David Scott Wishart
First released in 2009, MetaboAnalyst (www.metaboanalyst.ca) was a relatively simple web server designed to facilitate metabolomic data processing and statistical analysis. With continuing advances in metabolomics along with constant user feedback, it became clear that a substantial upgrade to the original server was necessary. MetaboAnalyst 2.0, which is the successor to MetaboAnalyst, represents just such an upgrade. MetaboAnalyst 2.0 now contains dozens of new features and functions including new procedures for data filtering, data editing and data normalization. It also supports multi-group data analysis, two-factor analysis as well as time-series data analysis. These new functions have also been supplemented with: (i) a quality-control module that allows users to evaluate their data quality before conducting any analysis, (ii) a functional enrichment analysis module that allows users to identify biologically meaningful patterns using metabolite set enrichment analysis and (iii) a metabolic pathway analysis module that allows users to perform pathway analysis and visualization for 15 different model organisms. In developing MetaboAnalyst 2.0 we have also substantially improved its graphical presentation tools. All images are now generated using anti-aliasing and are available over a range of resolutions, sizes and formats (PNG, TIFF, PDF, PostScript, or SVG). To improve its performance, MetaboAnalyst 2.0 is now hosted on a much more powerful server with substantially modified code to take advantage the server's multi-core CPUs for computationally intensive tasks. MetaboAnalyst 2.0 also maintains a collection of 50 or more FAQs and more than a dozen tutorials compiled from user queries and requests. A downloadable version of MetaboAnalyst 2.0, along detailed instructions for local installation is now available as well.

4 December 2012 in Metabolomics
Verified
Journal Article
Open access
PDF file
Jianguo XiaJianguo Xia
Jianguo Xia
DBDavid I Broadhurst
David I Broadhurst
MWMichael Wilson
Michael Wilson
David Scott WishartDavid Scott Wishart
David Scott Wishart
Metabolomics is increasingly being applied towards the identification of biomarkers for disease diagnosis, prognosis and risk prediction. Unfortunately among the many published metabolomic studies focusing on biomarker discovery, there is very little consistency and relatively little rigor in how researchers select, assess or report their candidate biomarkers. In particular, few studies report any measure of sensitivity, specificity, or provide receiver operator characteristic (ROC) curves with associated confidence intervals. Even fewer studies explicitly describe or release the biomarker model used to generate their ROC curves. This is surprising given that for biomarker studies in most other biomedical fields, ROC curve analysis is generally considered the standard method for performance assessment. Because the ultimate goal of biomarker discovery is the translation of those biomarkers to clinical practice, it is clear that the metabolomics community needs to start “speaking the same language” in terms of biomarker analysis and reporting-especially if it wants to see metabolite markers being routinely used in the clinic. In this tutorial, we will first introduce the concept of ROC curves and describe their use in single biomarker analysis for clinical chemistry. This includes the construction of ROC curves, understanding the meaning of area under ROC curves (AUC) and partial AUC, as well as the calculation of confidence intervals. The second part of the tutorial focuses on biomarker analyses within the context of metabolomics. This section describes different statistical and machine learning strategies that can be used to create multi-metabolite biomarker models and explains how these models can be assessed using ROC curves. In the third part of the tutorial we discuss common issues and potential pitfalls associated with different analysis methods and provide readers with a list of nine recommendations for biomarker analysis and reporting. To help readers test, visualize and explore the concepts presented in this tutorial, we also introduce a web-based tool called ROCCET (ROC Curve Explorer & Tester, http://www.roccet.ca). ROCCET was originally developed as a teaching aid but it can also serve as a training and testing resource to assist metabolomics researchers build biomarker models and conduct a range of common ROC curve analyses for biomarker studies.

18 May 2018 in Metabolomics
Verified
Journal Article
Open access
PDF file
DBDavid I Broadhurst
David I Broadhurst
RGRoyston Goodacre
Royston Goodacre
SRStacey Reinke
Stacey Reinke
Julia KuligowskiJulia Kuligowski
Julia Kuligowski
Ian WilsonIan Wilson
Ian Wilson
WDWarwick Dunn
Warwick Dunn
Background Quality assurance (QA) and quality control (QC) are two quality management processes that are integral to the success of metabolomics including their application for the acquisition of high quality data in any high-throughput analytical chemistry laboratory. QA defines all the planned and systematic activities implemented before samples are collected, to provide confidence that a subsequent analytical process will fulfil predetermined requirements for quality. QC can be defined as the operational techniques and activities used to measure and report these quality requirements after data acquisition. Aim of review This tutorial review will guide the reader through the use of system suitability and QC samples, why these samples should be applied and how the quality of data can be reported. Key scientific concepts of review System suitability samples are applied to assess the operation and lack of contamination of the analytical platform prior to sample analysis. Isotopically-labelled internal standards are applied to assess system stability for each sample analysed. Pooled QC samples are applied to condition the analytical platform, perform intra-study reproducibility measurements (QC) and to correct mathematically for systematic errors. Standard reference materials and long-term reference QC samples are applied for inter-study and inter-laboratory assessment of data.

1 January 2001 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LRLéonie M. Raamsdonk
Léonie M. Raamsdonk
BTBas Teusink
Bas Teusink
DBDavid I Broadhurst
David I Broadhurst
NZNianshu Zhang
Nianshu Zhang
AHAndrew Hayes
Andrew Hayes
SOStephen G. Oliver
Stephen G. Oliver

26 January 2009 in Analytical Chemistry
Verified
Journal Article
Closed access
EZEva Zelena
Eva Zelena
WDWarwick Dunn
Warwick Dunn
DBDavid I Broadhurst
David I Broadhurst
SFSue Francis-McIntyre
Sue Francis-McIntyre
KCKathleen M. Carroll
Kathleen M. Carroll
DKDouglas Kell
Douglas Kell